|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, DC 20549
|
|
______________________
|
|
FORM 8-K
|
|
CURRENT REPORT PURSUANT
|
|
TO SECTION 13 OR 15(D) OF THE
|
|
SECURITIES EXCHANGE ACT OF 1934
|
|
July 16, 2013
|
|
Date of Report (Date of earliest event reported)
|
|
BOVIE MEDICAL CORPORATION
|
|
(Exact name of registrant as specified in its Charter)
|
|
Delaware
|
012183
|
11-2644611
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
734 Walt Whitman Road, Melville, New York 11747
|
|
(Address of principal executive offices) (Zip Code)
|
|
(631) 421-5452
|
|
Registrant's telephone number, including area code
|
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders
|
On July 16, 2013, the following proposals were submitted to the stockholders of Bovie Medical Corporation (the “Company”) at its annual meeting of stockholders: (i) the election of seven (7) directors; (ii) the ratification of the appointment of Kingery & Crouse PA as the Company’s independent registered public accounting firm for the year ended December 31, 2013; (iii) the holding of a non-binding stockholder advisory vote on the compensation of named executive officers of the Company; and (iv) the holding of a non-binding stockholder advisory vote on the frequency of holding a non-binding advisory vote on the compensation of named executive officers of the Company.
The following are the final voting results for each proposal.
(i) The Company’s stockholders elected each of the following seven (7) directors to serve on its Board of Directors until their successors are duly elected and qualified by, the following vote:
|
Name of Directors
|
Votes For
|
Votes Withheld
|
|
Andrew Makrides
|
6,684,474
|
258,413
|
|
J. Robert Saron
|
6,793,146
|
151,074
|
|
George Kromer
|
6,677,498
|
266,722
|
|
Michael Norman
|
6,678,632
|
265,588
|
|
August Lentricchia
|
6,691,918
|
252,302
|
|
Michael Geraghty
|
6,748,146
|
196,074
|
|
Lawrence J. Waldman
|
6,657,202
|
287,018
|
(ii) The Company’s stockholders ratified the appointment of Kingery & Crouse PA as its independent registered public accounting firm for the year ended December 31, 2013 by the following vote:
|
Votes For
|
Votes Against
|
Votes Withheld
|
|
13,583,587
|
555,480
|
49,940
|
(iii) The Company’s stockholders approved the compensation of the named executive officers of the Company by the following vote:
|
Votes For
|
Votes Against
|
Votes Withheld
|
|
5,205,742
|
1,055,782
|
683,735
|
(iv) The Company’s stockholders selected one year as the rate of frequency for holding a non-binding advisory vote to approve the compensation of the named executive officers of the Company by the following vote:
|
Votes For One Year
|
Votes For Two Years
|
Votes For Three Years
|
|
4,653,880
|
101,894
|
2,118,084
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: July 16, 2013
|
BOVIE MEDICAL CORPORATION
|
|
|
By: /s/ Andrew Makrides
|
||
|
Andrew Makrides
|
||
|
Chief Executive Officer and
Chairman of the Board
|
3